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voltammetric detection of MDMA and its fatal
counterpart “Dr Death” (PMA)†
Loanda R. Cumba,ab Jamie P. Smith,b Khaled Y. Zuway,b Oliver B. Sutcliﬀe,b
Devaney R. do Carmoa and Craig E. Banks*b
The simultaneous detection of substances present in drugs of abuse is increasingly important since some
materials are known for their high mortality rate. One drug that received considerable attention is para-
methoxyamphetamine (PMA), commonly known as ‘Dr Death’ – this substance is linked with several
deaths internationally and can often be found together with 3,4-methylenedioxymethamphetamine
(MDMA) in drugs sold under the alias “ecstasy”, a very popular drug of abuse. This work reports for the
ﬁrst time the detection and quantiﬁcation of MDMA and PMA simultaneously through an electrochemical
technique using screen-printed graphite electrodes (SPEs). The electroanalytical sensing of MDMA/PMA,
MDMA and PMA are explored directly at bare unmodiﬁed SPEs yielding a detection limit (3s)
corresponding to 0.25 mg mL1/0.14 mg mL1 for MDMA/PMA, 0.04 mg mL1 MDMA and 0.03 mg mL1
PMA. Raman spectroscopy and presumptive colour tests were also performed on MDMA/PMA, MDMA
and PMA using the Marquis, Mandelin, Simon's and Robadope tests but were found to not be able
discriminate when PMA and MDMA are both present in the same samples. We report a novel
electrochemical protocol for the sensing of PMA and MDMA which is independently validated in
a synthetic (MDMA/PMA) sample with HPLC.Introduction
3,4-Methylenedioxymethamphetamine (MDMA, Scheme 1) is
a synthetic entactogen which shares a structural similarity to
methamphetamine and acts as a central nervous system (CNS)
stimulant producing mood enhancement, increased energy and
other empathetic eﬀects by increasing the intra-synaptic
concentrations of the key neurotransmitters serotonin, dopa-
mine and norephinephrine.1–5 MDMA was rst synthesised by
Merck in 1912 as a potential appetite suppressant, and over the
next seventy years, a number of researchers explored the
psychedelic properties of MDMA with little success.6 During the
1970s and 80s MDMA surfaced on the recreational drugs
market, its widespread abuse and potential long-term health
eﬀects ledmany countries to prohibit its possession, supply and
manufacture. Currently in the UK, MDMA (or “ecstasy”) is
controlled as a Class A, Schedule 1 substance due to its illicitNESP – Universidade Estadual Paulista,
rasil Centro, 56 CEP 15385-000, Ilha
of Science and the Environment, Division
nchester Metropolitan University, Chester
c.banks@mmu.ac.uk; Web: http://www.
7 6831; Tel: +44 (0)161 247 1196
tion (ESI) available. See DOI:use as a recreational drug and its implication in a number of
highly publicized fatalities.7–13 It is usually found in tableted
form (containing 60–70 mg MDMA) with each batch being
stamped with a particular motif, e.g. aMitsubishi™ logo, smiley
faces or letters.
Since the global prohibition of MDMA and its precursors (i.e.
3,4-methylenedioxyphenyl-2-propanone, piperonal, safrole and
isosafrole) a wide range of structurally-related phenethylamines
have appeared on the recreational drugs market, including the
designer drug, 4-methoxyamphetamine (PMA, Scheme 1). As
a synthetic entactogen, PMA acts on the CNS producing mood
enhancement, heightened sexual arousal and increased energy
by increasing the release of intra-synaptic concentration sero-
tonin and also inhibiting its reuptake.14 Animal models suggest
that PMA is more toxic, than MDMA, resulting in hyperthermia
(i.e. serotonin syndrome) due to the enhancement of serotonin
release and the delayed onset of action.15,16 It is believed thatScheme 1 The structure of ()-3,4-methylenedioxymethamphet-
amine hydrochloride (MDMA) and the synthesis of ()-4-methox-
yamphetamine hydrochloride (PMA).
This journal is © The Royal Society of Chemistry 2016
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View Article Onlinea synergistic eﬀect of taking PMA in combination with MDMA
and alcohol may be particularly hazardous.17,18 PMA (or “Dr
Death”) is not a recreational drug, which is sought aer, rather it
is usually encountered as a misrepresentation of MDMA,
leading to serious adverse eﬀects and fatalities.2,17 Due to the
high demand of MDMA, illicit drug suppliers have been known
to distribute PMA as “ecstasy” leading to a number of hospi-
talisations and fatalities. PMA is, similar to MDMA, usually
found in tableted form (containing 40–70 mg PMA) with each
batch being stamped with either a Mitsubishi™ or Superman
logo.2 Consequently PMA is linked with several deaths inter-
nationally and can oen be found together with 3,4-methyl-
enedioxymethamphetamine (MDMA) in drugs sold under the
alias “ecstasy”.
A number of groups have reported the simultaneous detec-
tion and quantication of MDMA and PMA using HPLC,19,20 GC-
MS21,22 and LC-MS,23–25 however, these methods are not suitable
for rapid and routine on-site testing. DanceSafe (Oakland, CA)
have advocated the use of the Marquis test (1% formaldehyde in
concentrated sulphuric acid) for the purposes of pill testing and
discrimination between PMA and MDMA,2 however, with no
published data (with either a secondary colour test and/or
a conrmatory chromatographic assay) verifying this approach
in real samples, the method is awed and the potential for false
positives is highly probable.
Electrochemistry is an advantageous analytical tool that is
adaptable to an in-the-eld device, in light of its portability, and
can exhibit sensitivity and selectivity toward many target ana-
lytes.26–34 Our previous work on the development of robust
electrochemical methods for the sensing of Novel (or New)
Psychoactive substances (NPSs), in their pure form33 or in the
presence of common adulterants,34 has the potential to be
rapid, simple and cost-eﬀective on-the-spot analytical screening
tools with screen-printed graphite electrodes (SPEs). In this
paper the simultaneous detection of para-methoxyamphet-
amine (PMA), and 3,4-methylenedioxymethamphetamine
(MDMA) is shown to be viable for the rst time using screen-
printed electrochemical sensing platforms. Prior electro-
chemical work has reported the electrochemical oxidation of
MA, MDA and MDMA at (only) glassy carbon electrodes and was
extended to the sensing of MDMA in seized samples and in
human serum.35 The electroanalytical sensing of MDMA/PMA,
MDMA and PMA are explored in model (buﬀer) solutions for the
rst time using a range of commercially available electrode
substrates (glassy carbon, boron-doped diamond and screen-
printed electrodes). The detection of PMA and MDMA is also
explored with presumptive colour tests and Raman analysis.
Last, the electrochemical protocol is applied to the sensing of
PMA and MDMA in a synthetic street samples and compared to
high performance liquid chromatography.
Experimental
The chemicals were of commercial quality (obtained from
Sigma-Aldrich, Gillingham, UK) and used without further
purication. ()-3,4-Methylenedioxymethamphetamine hydro-
chloride (MDMA) was obtained, under Home Oﬃce licence,This journal is © The Royal Society of Chemistry 2016from Sigma-Aldrich (Gillingham, UK) and used without further
purication. ()-4-Methoxyamphetamine hydrochloride (PMA)
was prepared as described below. The simulated “ecstasy”
sample, containing PMA : MDMA (30 : 70% w/w) was prepared
by mixing PMA (17.25 mg) and MDMA (37.4 mg) and homoge-
nising the sample prior to analysis. 1H- and 13C-NMR spectra
were acquired on a JEOL AS-400 (JEOL, Tokyo, Japan) NMR
spectrometer operating at a proton resonance frequency of 400
MHz. Samples of PMA (10 mg/0.60 mL) were dissolved in
DMSO-d6 and ltered prior to analysis. Infrared spectra were
obtained in the range 4000–400 cm1 using a ThermoScientic
Nicolet iS10ATR-FTIR instrument (ThermoScientic, Rochester,
USA). GC-MS spectra were recorded on an Agilent 6890 gas
chromatograph with split-splitless injection (sample volume: 1
mL) and a HP-5MS column (30 m  0.25 mm, 0.25 mm lm
thickness). Helium (He) was used as the carrier gas at a ow rate
of 1.0 mL min1. The GC was coupled to an Agilent 5973 MSD
(EI, 70 eV, TIC mode scanningm/z 50–500) and injector port was
set at 275 C, the transfer line at 280 C. The following
temperature program was used: 60 C for 3 min, 20 C min1 to
280 C, 280 C for 5 min. High-resolution mass spectra were
recorded on an Agilent 1260 innity LC coupled to a 6540 UHV
accurate mass Q-TOF mass spectrometer by looped injection
using electrospray ionisation (ESI, collision energy: 15 eV).
Ultraviolet spectra were obtained using a Unicam 300 UV
spectrophotometer (ThermoScientic, Rochester, USA). Thin-
Layer Chromatography (TLC) was carried out on aluminium-
backed SiO2 plates (Merck, Darmstadt, Germany) and spots
were visualised using ultra-violet light (254 nm). Melting points
were determined using Gallenkamp 5A 6797 apparatus (Gal-
lenkamp, Germany) and are uncorrected. Optical rotation
values [a]D22 (10
1 deg cm2 g1) were performed on a Bellingham
& Stanley ADP-220 polarimeter (Bellingham & Stanley, Tun-
bridge Wells, UK). All solutions were prepared using deionised
water of resistivity no less than 18.2 MU cm and were vigorously
degassed prior to electrochemical measurements with high
purity, oxygen free nitrogen. Solutions containing 1000 mg mL1
MDMA/PBS (pH 7) and 1000 mgmL1 PMA/PBS (pH 7) were used
on the day of preparation. Working solutions of lower concen-
trations were prepared by appropriate dilution of the stock
solution as mentioned above.Synthesis of ()-4-methoxyamphetamine hydrochloride
(PMA)
The title compound was prepared, at the University of Strath-
clyde, using an adaptation of the synthesis reported by Liu
et al.36 as an oﬀ-white crystalline powder (1.12 g, 56%) aer
recrystallization from ethanol–diethyl ether: mp (ethanol–
diethyl ether) 211–213 C (Lit. 210–211 C37); Rf [SiO2, EtOAc–n-
hexane (1 : 3)] ¼ 0.1; [a]D22 ¼ 0 (c ¼ 0.5 g/100 mL, MeOH); IR
(ATR-FTIR): 2917.3 (NH3
+), 1515.0 (Ar, C]C); 1037.2 (Ar, O–
CH3), 857.5 cm
1 (Ar, 1,4-disub.); 1H-NMR (400 MHz, DMSO-d6)
d 1H (ppm) ¼ 8.18 (3H, bs, CH2CH(CH3)NH3+), 7.16 (2H, d, J ¼
5.0 Hz, AA0BB0), 6.90 (2H, d, J ¼ 5.0 Hz, AA0BB0), 3.73 (3H, s,
CH3O–Ar), 3.33 (1H, m), 2.98 (1H, m, J ¼ 13.3, 5.0 Hz), 2.58 (1H,
m, J ¼ 13.3, 9.2 Hz) and 1.10 ppm (3H, d, J ¼ 8.0 Hz,Anal. Methods, 2016, 8, 142–152 | 143
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View Article OnlineCH2CH(CH3)NH3
+); 13C-NMR (100 MHz, DMSO-d6) d
13C (ppm)
¼ 17.4 (CH2CH(CH3)NH2), 39.1 (CH2CH(CH3)NH2), 48.0 (CH2-
CH(CH3)NH2), 54.9 (OCH3), 113.6 (Ar-CH), 128.4 (Ar-qC), 130.2
(Ar-CH) and 158.0 ppm (Ar-qC); LRMS (EI+, 70 eV): m/z ¼ 166
(0.5%, [M + H]), 122 (100), 121 (34), 91 (17), 77 (22) and 44 (45);
HRMS (ESI+, 15 eV) calculated for [M + H] C10H16NO: 166.1226,
found: 166.1229.
High performance liquid chromatography (HPLC)
Reverse phase high-performance liquid chromatography was
performed with an integrated Agilent HP Series 1100 Liquid
Chromatograph (Agilent Technologies, Wokingham, UK) tted
with an in-line degasser, 100-place auto-injector and diode array
UV absorbance detector monitoring at 210 nm. Data analysis was
carried out using ChemStation for LC (Ver. 10.02) soware (Agi-
lent Technologies, Wokingham, UK). The mobile phase was
aqueous potassium dihydrogen phosphate buﬀer (0.05 M, pH 3.2
 0.02) : acetonitrile (90 : 10% v/v); the ow rate was 1.2 mL
min1 with an injection volume of 10 mL. Six replicate injections
of each calibration standard were performed. The stationary
phase (ACE 3 C18, 150 mm  4.6 mm i.d., particle size: 3 mm)
used in the study was obtained fromHiChrom Limited (Reading,
UK). The column was tted with a guard cartridge (ACE 3 C18)
and maintained at an isothermal temperature of 22 C with an
Agilent HP Series 1100 column oven with a programmable
controller (Agilent Technologies, Wokingham, UK).
Calibration standards
2.0 mg of ()-3,4-methylenedioxymethamphetamine hydro-
chloride (MDMA) and 2.0 mg of ()-4-methoxyamphetamine
hydrochloride (PMA) were weighed accurately into a 10.0 mL
clear glass volumetric ask and diluted to volume with mobile
phase to give a solution containing the two components at 200.0
mg mL1. This solution was then further diluted with mobile
phase to give calibration standards containing 40.0 mg mL1,
20.0 mg mL1, 10.0 mg mL1, 2.5 mg mL1 and 1.25 mg mL1 of
each analyte respectively.
Specicity standards
5.0 mg sucrose, mannitol and lactose were weighed accurately
into separate 100.0 mL clear glass volumetric ask and diluted
to volume with mobile phase to give solutions containing the
components at 50 mg mL1 of each analyte. This solution was
then further diluted (5) with mobile phase to give specicity
standards containing 10.0 mg mL1 of each analyte respectively.
HPLC method validation
The HPLC method was validated in accordance with the ICH
guidelines38 using the following parameters: linearity, accuracy,
precision, specicity, limit of detection (LOD), limit of quanti-
cation (LOQ) and system suitability [resolution (Rs), column
eﬃciency (N), peak asymmetry (As)]. Linearity, precision and
system suitability tests: six replicate injections of the calibration
standards (vide supra) were performed and the data analysed
under the same conditions. The %RSD was calculated for each144 | Anal. Methods, 2016, 8, 142–152replicate sample. Accuracy: determined from three replicate
concentrations near the test concentration (80%, 100%, and
120%, two replicate injections of each concentration). The
percentage recovery and %RSD were calculated for each of the
replicate samples. Specicity: six replicate injections of the
specicity standards (vide supra) were performed and the data
analysed under the same conditions. Limits of detection and
quantication: six replicate injections of the calibration stan-
dards (vide supra) were performed and the data analysed under
the same conditions. The limits of detection and quantication
were calculated based on the standard deviation of the response
and the slope.
Presumptive tests
Presumptive tests were carried out according to the United
Nations recommended guidelines.39 The following standard
presumptive tests applied in this study: (i) Marquis; (ii) Man-
delin; (iii) Simon's and (iv) Robadope test(s). The preparation of
the reagents and test procedure is detailed in the ESI.† Six
repetitive tests of each compound were conducted and negative
control samples were used in all tests. The ESI† contains images
of the spotting tiles (aer 5 minutes). Test solutions containing
25 : 75% v/v; 50 : 50% v/v and 75 : 25% v/v (PMA : MDMA) were
prepared by mixing appropriate volumes of solutions (10 mg
mL1) of the reference standards in methanol.
Electrochemistry
Voltammetric measurements were carried out using a Palmsens
3 (Palm Instruments BV, The Netherlands) potentiostat/galva-
nostat and controlled by PSTrace soware version 4.4 for
Windows 7. All electrochemical measurements were performed
at room temperature (cyclic voltammetry and diﬀerential pulse
voltammetry). Diﬀerential pulse voltammetry parameters (E
step, E pulse, t pulse and scan rate) were optimised prior to
experimentation. A conventional three-electrode system was
used. For each voltammogram acquired, a new/separate screen-
printed graphite electrode was used, with the exception of the
scan rate study. This highlights the reproducibility of the SPEs.
Experiments were performed using screen-printed graphite
electrode (SPE), boron-doped diamond electrode (BDD) and
glassy carbon electrode (GC). All the working electrodes used in
the analyses had 3 mm diameter working area. Screen-printed
graphite electrodes were fabricated in-house with appropriate
stencil designs using a DEK 248 screen-printing machine (DEK,
Weymouth, U.K.). The screen-printed graphite electrodes (SPEs)
utilized consist of a graphite working electrode, a graphite
counter electrode and a silver/silver chloride reference elec-
trode. The screen-printed graphite electrodes, which have a 3
mm diameter working electrode were fabricated in-house with
appropriate stencil designs using a microDEK 1760RS screen-
printing machine (DEK, Weymouth, UK). This screen-printed
electrode design has been previously reported.26,28,29,33,40–44 For
the case of each fabricated electrode, rst a carbon ink formu-
lation (Product Code: C2000802P2; Gwent Electronic Materials
Ltd, UK), which is utilized for the eﬃcient connection of all
three electrodes and as the electrode material for both theThis journal is © The Royal Society of Chemistry 2016
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View Article Onlineworking and counter electrodes, was screen-printed onto
a polyester (Autostat, 250 micron thickness) exible lm. Aer
curing the screen-printed carbon layer in a fan oven at 60
degrees Celsius for 30 minutes, next a silver/silver chloride
reference electrode was included by screen-printing Ag/AgCl
paste (Product Code: C2040308D2; Gwent Electronic Materials
Ltd, UK) onto the polyester substrates, which was subse-
quently cured once more in a fan oven at 60 degrees for 30
minutes. Finally, a dielectric paste (Product Code:
D2070423D5; Gwent Electronic Materials Ltd, UK) was then
printed onto the polyester substrate to cover the connections
and dene the active electrode areas, including that of the
working electrode (3 mm diameter). Aer curing at 60 degrees
for 30 minutes the SPEs are ready to be used. The reproduc-
ibility and repeatability of the fabricated batches of electrodes
were explored through comparison of cyclic voltammetric
responses using Ru(NH3)
2+/3+ redox probe in 1 M KCl. Analysis
of the voltammetric data revealed the % relative standard
deviation (%RSD) to correspond to no greater than 0.82% (n ¼
20) and 0.76% (n ¼ 3) for the reproducibility and repeatability
of the fabricated GSPEs (for use in electroanalysis). For each
electrochemical experiment/scan, a new screen-printed
graphite electrode was used. All diﬀerential pulse voltammo-
grams were baseline corrected.Raman
Raman Spectroscopy was performed using a ‘Renishaw InVia’
spectrometer with a confocal microscope 50 objective,Fig. 1 Cyclic voltammograms of SPE (A) in presence (500 mg mL1) and
and (C) in presence (250 mg mL1)/(500 mg mL1) and absence of MDMA
This journal is © The Royal Society of Chemistry 2016spectrometer with an argon laser of 514.3 nm excitation. Spectra
were recorded using a 10 s exposure time for 1 accumulation.
Three spectra were recorded and an average representation is
presented within the manuscript.
Analysis of synthetic sample: “ecstasy synthetic”
For the electrochemical determination of MDMA/PMA solutions
were prepared using carefully weighed samples of “synthetic
ecstasy” in PBS (pH 7). Subsequently, the solution was sonicated
for 3 minutes for homogenization and ltered to remove
remaining undesirable insoluble materials. A total of ve seized
ecstasy tablets were analysed viaHPLC and the presence of PMA
was not detected in either tablet, so a sample containing the two
substances was created. PMA is a lethal substance when
administered in substantial quantities, but produces similar
eﬀects to MDMA. As it is a cheaper substance, it is occasionally
added to MDMA in ecstasy tablets to lower the cost of the drug.
Results and discussion
Electrochemical detection of MDMA and PMA
First, cyclic voltammetric measurements were performed using
screen-printed graphite electrodes (SPEs) in solutions contain-
ing PMA, MDMA and MDMA/PMA in phosphate buﬀer (pH 7).
Fig. 1A shows the cyclic voltammograms of SPE in the presence
(500 mg mL1) and absence of PMA. In the case of PMA a well-
dened oxidation peak is observed at +1.162 V. Fig. 1B shows
the cyclic voltammograms in the presence (250 mg mL1) andabsence of PMA, (B) in presence (250 mg mL1) and absence of MDMA
/PMA in PBS (pH 7) (scan rate: 100 mV s1).
Anal. Methods, 2016, 8, 142–152 | 145
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View Article Onlineabsence of MDMA using the SPEs. The cyclic voltammogram in
the presence of MDMA shows the oxidation peaked in +0.924 V.
Fig. 1C shows the cyclic voltammograms in the presence of (250
mg mL1)/(500 mg mL1) and absence of MDMA/PMA where two
oxidation peaks can be observed; peak I at +0.92 V due to
oxidation of MDMA and peak II at +1.20 V is due to oxidation of
PMA. The sole presence of an oxidation peak for all the analytes
suggests an electrochemically irreversible reaction.
Diﬀerent electrodes were explored towards the electro-
chemical oxidation of the target analytes to provide a direct
comparison with the response obtained using the screen-prin-
ted graphite electrode. Fig. SI-1† shows the electrochemical
response of the SPE, boron doped diamond (BDD) and glassy
carbon (GC). For the target analyte MDMA, the SPE shows an
optimal response with the electrochemical oxidation occurring
at the lowest overpotential (+0.99 V) with the highest current
density (145.42 mA cm2) when compared with the BDD (+1.19 V
and 127.44 mA cm2) and GC (+1.15 V and 137.77 mA cm2). The
current densities were calculated using the geometric area of
the electrode surfaces. For PMA, the GC (+1.28 V) and SPE (+1.29
V) show the potential response similar, but the GC show the
highest current density (376.22 mA cm2) when compared with
the BDD (229.70 mA cm2) and SPE (252.37 mA cm2). The
diﬀerence of current density of the GC and SPE does not make
the GC advantageous because this electrode needs to go
through a pre-treatment step each time it is used, which is not
necessary for the SPE because aer each use the electrode is
disposed thereby gaining time. In the case of the MDMA/PMA,
the SPE exhibits the optimal voltammetric response (88.99 mA
cm2 MDMA/89.97 mA cm2 PMA) and lowest overpotential
(+0.97 V MDMA/+1.26 V PMA) when compared with the BDD
(+1.15 V and 71.65 mA cm2 MDMA/+1.45 V and 82.80 mA cm2Fig. 2 Diﬀerential pulse voltammograms obtained utilizing the screen-
concentrations in the range of 0.50–4.98 mg mL1 (in phosphate buﬀer
analytical curve corresponding to the anodic peak for the oxidation of M
pulse: 0.05 s; scan rate: 0.005 V s1; t-eq. 1 s).
146 | Anal. Methods, 2016, 8, 142–152PMA) and GC (+1.18 V and 77.75 mA cm2 MDMA/+1.51 V and
83.34 mA cm2 PMA). The SPE was chosen since it exhibits the
best electrochemical response, being an electrode for easy
handling, low cost and high reproducibility.
Next, the eﬀect of scan rate upon the electrochemical
oxidation were explored for the target analytes in PBS (pH 7). A
plot of peak height against the square-root of scan rate was
constructed for PMA (Ip/A ¼ 7.10  105 A (V s1)0.5 + 1.21 
106 A R2 ¼ 0.997), MDMA (Ip/A ¼ 3.05  105 A (V s1)0.5 +
1.17  106 A, R2 ¼ 0.993) and MDMA/PMA (Ip/A ¼ 2.87  105
A (V s1)0.5 + 6.61  108 A, R2 ¼ 0.996/Ip/A ¼ 3.49  105 A (V
s1)0.5  7.10  107 A, R2 ¼ 0.990) and found to be linear in
all cases indicating a diﬀusional electrochemical process. The
eﬀect of the pH on the voltammetric response (diﬀerential pulse
voltammetry) were also explored for the target analytes PMA,
MDMA and MDMA/PMA in various buﬀers. Fig. SI-2† shows the
voltammograms for the SPE in (A) 500 mg mL1 PMA/PBS, (B)
500 mg mL1 MDMA/PBS and (C) 500 mg mL1 PMA + 250 mg
mL1 MDMA/PBS (pH 7) over a range of pH (2–12). It can be
seen that the oxidative peak exhibits a potential at more nega-
tive oﬀset to regions with increasing pH (acid to basic) and a fall
in current values of the oxidative peak at basic pH with a linear
relationship for PMA of (Ep/V ¼ 0.03 V per pH + 1.27 V; R2 ¼
0.945) with a gradient of 28.30 mV per pH that value is close to
that expected for a 1 proton and 2 electron process (30 mV per
pH unit at 25 C), for MDMA to (Ep/V¼ 0.02 V per pH + 1.00 V;
R2 ¼ 0.988) with a gradient of 20.50 mV per pH which is close to
that expected for a 1 proton and 3 electron process (20 mV per
pH unit at 25 C) andMDMA/PMA (Ep/V¼0.02 V per pH + 1.01
V; R2 ¼ 0.978)/(Ep/V ¼ 0.03 V per pH + 1.34 V; R2 ¼ 0.993)
sustaining the response of individually analysed analytes. The
appearance of one new peak (between +0.6 and +0.7 V) above pHprinted graphite electrodes by adding aliquots of MDMA (pH 7.0) at
supporting electrolyte); the dotted line represents a blank. (inset) An
DMA over the concentration range (E-step: 0.002 V; E-pulse: 0.1 V; t-
This journal is © The Royal Society of Chemistry 2016
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View Article Online9 is related with the acid–base properties of the MDMA and is
probably due to the existence of an electron lone-pair.35 The pH
of 7 was chosen due to the good electrochemical responses
compared with other pHs.
Diﬀerential pulse voltammetry was next utilised to explore
the electroanalytical eﬃciency of the proposed protocol through
utilising the SPEs by adding aliquots of MDMA (pH 7.0) at
concentrations over the range of 0.50–4.98 mg mL1 into a pH 7
phosphate buﬀer; Fig. 2 shows the voltammetry. Through the
additions of MDMA there is an increase in the current intensity
of the oxidation peak and a small displacement of potential into
positive regions. The insert graph shows the linear calibration
curve obtained from the diﬀerential pulse voltammograms (Ip/
mA ¼ 0.11 A mL g1 [mg mL1] + 0.01 mA; R2 ¼ 0.999 and N ¼ 3)
with a limit of detection (3s) found to correspond to 0.04 mg
mL1 and a relative standard deviation (%RSD) of 2.14%. Again
note that each additions is made with a new SPE. Various
methods have been used before in the detection and quanti-
cation of MDMA45–48 and Table 1 summarises these with the
results of this work also presented and compared demon-
strating our approach is competitive.
Fig. 3 illustrates the voltammetric behaviour of the SPEs
through the addition of aliquots of PMA (in phosphate buﬀer
pH 7.0) at concentrations over the range of 0.50–4.98 mg mL1.
The linear calibration curve of the anodic current of oxidation
peak as a function of PMA concentration is presented in the
insert of Fig. 3 (Ip/mA ¼ 0.21 A mL g1 [mg mL1] + 0.07 mA, R2 ¼
0.999 and N ¼ 3) with a limit of detection (3s) found to corre-
spond to 0.03 mg mL1 and relative standard deviation (%RSD)
of 4.3. Last, the analytical performance of MDMA/PMA using
SPEs were explored (see Fig. 4) with additions made over the
range of 2.00–19.60 mg mL1 for MDMA (Ip/mA ¼ 0.09 A mL g1
[mg mL1] + 0.08 mA; R2 ¼ 0.999; N ¼ 3) and 2.00–19.60 mg mL1
for PMA (Ip/mA ¼ 0.18 A mL g1 [mg mL1] + 0.03 mA; R2 ¼ 0.999;
N ¼ 3). The limit of detection (3s) was found to correspond to
0.14 mg mL1 for PMA (Fig. 4 inset) and 0.25 mg mL1 for MDMA
(Fig. 4 inset) and relative standard deviations (%RSD) of 3.2%
MDMA and 3.8% for PMA. Table 1 summarises these electro-
analytical results and benchmarks these against the current
literature demonstrating our work is highly competitive.T
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s)Alternative approaches for the sensing of MDMA/PMA
Raman spectroscopic. Raman spectroscopy is commonly
utilised for rapid and reliable characterisation in the literature.
Raman spectra of MDMA, PMA and a MDMA/PMA mixture are
presented in Fig. SI-3.† The MDMA spectrum shows a response
similar that reported in the literature.49,50 The Raman spectrum
of PMA is not found in the literature, but it is possible to identify
peaks similar to the spectra of amphetamine which is expected
since PMA is an amphetamine analogue diﬀering only by the
ether group attached to the aromatic ring. The application of
Raman spectroscopy towards the MDMA and PMA mixture (see
Fig. SI-3B†), however does not give a satisfactory response
because of poor resolution between the two signals suggesting
that utilization of Raman spectroscopy towards the simulta-
neous detection of MDMA and PMA is not practicable.This journal is © The Royal Society of Chemistry 2016 Anal. Methods, 2016, 8, 142–152 | 147
Fig. 3 Diﬀerential pulse voltammograms of the screen-printed graphite electrode by adding aliquots of PMA (in phosphate buﬀer pH 7.0) at
concentrations in the range of 0.50–4.98 mg mL1 (in phosphate buﬀer supporting electrolyte); the dotted line represents a blank. (inset) An
analytical curve corresponding to the anodic peak for the oxidation of PMA over the concentration range (E-step: 0.002 V; E-pulse: 0.1 V; t-
pulse: 0.05 s; scan rate: 0.005 V s1; t-eq. 1 s).
Fig. 4 Diﬀerential pulse voltammograms obtained utilizing the screen-printed graphite electrodes by adding aliquots of MDMA/PMA (in
phosphate buﬀer pH 7.0) at concentrations in the range of 2.00–19.60 mg mL1 (in phosphate buﬀer supporting electrolyte); the dotted line
represents a blank. (inset) An analytical curve corresponding to the anodic peak for the oxidation of PMA andMDMA over the concentration range
(E-step: 0.002 V; E-pulse: 0.1 V; t-pulse: 0.05 s; scan rate: 0.005 V s1; t-eq. 1 s).
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View Article OnlinePresumptive colour tests. Presumptive colour tests for the
two analytes were carried out according to the United Nations
recommended guidelines.39 The following standard presump-
tive tests were applied in this study: (i) Marquis test; (ii) Man-
delin test; (iii) Simon's test and (iv) Robadope test. The
preparation of the reagents and test procedure is detailed in the
Experimental section. A solution of each reference standard (10148 | Anal. Methods, 2016, 8, 142–152mg mL1) was prepared in methanol and 1–2 drops placed into
a dimple well of a spotting tile. The required presumptive test
reagent (1–2 drops) was then added and any colour change or
other noticeable eﬀect occurring immediately on addition of the
reagents was noted and observations were made again aer 5
min. The results (see ESI, SI-4†) indicated that the secondary
amine, MDMA, gave a positive reaction with Marquis, MandelinThis journal is © The Royal Society of Chemistry 2016
Fig. 5 (a) Representative chromatogram of a solution containing PMA
(10 mgmL1, peak b) and MDMA (10 mgmL1, peak c) obtained using an
ACE 3 C18 column (150 mm  4.6 mm i.d., particle size: 3 mm); ﬂow-
rate: 1.2 mL min1; mobile phase: aqueous potassium dihydrogen
phosphate buﬀer (0.05 M, pH 3.2  0.02) : acetonitrile (90 : 10% v/v);
detector wavelength (UV): 210 nm; (b) representative chromatogram
of test mixture (10 mgmL1) containing PMA andMDMA (30 : 70%w/w)
obtained using an ACE 3 C18 column (150 mm  4.6 mm i.d., particle
size: 3 mm); ﬂow-rate: 1.2 mLmin1; mobile phase: aqueous potassium
dihydrogen phosphate buﬀer (0.05 M, pH 3.2  0.02) : acetonitrile
(90 : 10% v/v); detector wavelength (UV): 210 nm. The t0 was deter-
mined from the tR of a solution of uracil (10 mg mL
1, peak a).
Fig. 6 Diﬀerential pulse voltammograms following a series of standard
16.70 mg mL1 for PMA and MDMA respectively (in phosphate buﬀer s
analytical curve corresponding to the anodic peak for the oxidation of (B)
pulse: 0.1 V; t-pulse: 0.05 s; scan rate: 0.005 V s1; t-eq. 1 s).
This journal is © The Royal Society of Chemistry 2016
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View Article Onlineand Simon's reagents, whilst the primary amine, PMA, gave
a positive reaction with the Robadope reagents. Solutions con-
taining 25 : 75% v/v; 50 : 50% v/v and 75 : 25% v/v
(PMA : MDMA) were prepared bymixing appropriate volumes of
solutions (10 mg mL1) of the reference standards in methanol
and screened against the standard tests. The data (see SI-5†)
indicated that in all cases the test reagents (when compared to
the pure standards) conrmed the presence of MDMA (even at
concentrations circa. 25% v/v), however, the presence of PMA
(indicated by a positive reaction with Robadope reagent) was
not as easy to discriminate using this method even when
present at high concentrations (circa. 75% v/v), demonstrating
that the utilisation of this presumptive colour test in particular
for products containing these two compounds is potentially
problematic and cannot be relied upon in these cases. The
simulated sample of MDMA adulterated with PMA (30% w/w),
was screened against the standard tests and observed to give
analogous results to the mixture containing 25 : 75% w/w
(PMA : MDMA). The sample gave a positive reaction withadditions of “ecstasy” over the range 0.00–14.80 mg mL1 and 0.00–
upporting electrolyte); the dotted line represents a blank. (inset) An
MDMA and (C) PMA over the concentration range (E-step: 0.002 V; E-
Anal. Methods, 2016, 8, 142–152 | 149
Table 2 Parameters obtained of the linear response of PMA/MDMA
and the comparison of the electrochemical and high performance
liquid chromatography (HPLC) results
Ecstasy (synthetic) PMA MDMA
Linear concentration range (mg mL1) 0.00–14.80 0.00–16.70
Slope of calibration graph (A mL g1) 0.24 0.33
Intercept (mA) 0.76 2.21
Correlation coeﬃcient 0.998 0.996
Relative standard deviation (%RSD) 4.38 2.33
Purity Total PMA MDMA
Electrochemical w/w% 99.37 31.53 67.84
HPLC w/w% 100.02 31.51 68.49
Analytical Methods Paper
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View Article OnlineMarquis, Mandelin and Simon's reagents indicating that the
sample does indeed contain MDMA, however, the colour
observed with Robadope reagent was a less intense rose colour
than that observed with the pure PMA reference standard,
indicating that there may indeed be interference between the
mixture of components and test reagents which may be
encountered by law enforcement. In summary, Raman spec-
troscopy and presumptive colour tests fail to distinguish
between PMA and MDMA and only electrochemistry provides
a useful sensing approach.
HPLC method development for MDMA/PMA and analysis of
ecstasy (synthetic) tablets. A number of groups have reported
utilising HPLC and LC-MS to separately determine PMA and
MDMA in the toxicological screening of the analytes,19,20,23–25
however, no fully validated methods (or limits of detection and
quantication) for the substances have, to-date, been reported.
A HPLC chromatographic method was developed employing an
isocratic elution (see Experimental section), to ensure both
optimal detection of the analytes and a rapid analysis time. The
selection of the non-specic lower wavelength (210 nm) was
based on the previous work reported by Mu¨ller et al.19 The two
baseline resolved (Rs ¼ 2.2) analytes eluted at 9.3 (PMA) and 9.9
(MDMA) minutes respectively (Fig. 5a) with peak fronting (As
0.77) observed in both cases. Calibration standards were
prepared and PMA demonstrated a linear response (r2 ¼ 0.999)
over a 1.25–40.0 mg mL1 range with excellent repeatability (%
RSD ¼ 0.03–0.41, n ¼ 6). The limits of detection and quanti-
cation for PMA were determined as being 0.08 and 0.26 mg
mL1. The method was also suitable for the detection and
quantication of MDMA, which exhibited a similar UV response
at 210 nm. MDMA also demonstrated a linear response (r2 ¼ 1),
over the same calibration range as PMA, with excellent repeat-
ability (%RSD ¼ 0.1–0.38, n ¼ 6) and the limits of detection and
quantication determined to be 0.04 mg mL1 and 0.12 mg mL1
respectively. The HPLC validation parameters are summarised
in Table SI-1.† The accuracy of the assay was determined from
three concentrations near the test concentration (80%, 100%,
and 120%). The percentage recovery (%assay) and %RSD were
calculated for each of the replicate samples and demonstrated
excellent accuracy (PMA: 0.78%, n ¼ 9, MDMA: 0.58%, n ¼ 9)
within the desired concentration range. All the results are
within acceptable limits (100 2%) (Table SI-2†). The selectivity
of the method against UV-inactive analytes (sucrose, mannitol,
and lactose, 10 mg mL1), which are commonly used as diluents
were shown not to interfere with the three target analytes.
To demonstrate if our proposed method could selectively
detect and quantify the components in a potential street sample
of MDMA adulterated with PMA a simulated sample was
prepared by mixing the two components in a ratio of 70 : 30%
w/w. The simulated sample was homogenised and analysed, in
triplicate, using the validated HPLC method at a concentration
of 10 mg mL1 (Fig. 5b). The results conrm that the sample
contains the two alleged components (tR ¼ 9.4 min [minor,
PMA, 31.51% w/w, %RSD ¼ 0.14%, n ¼ 3] and tR ¼ 9.9 min
[major, MDMA, 68.49% w/w, %RSD ¼ 0.07%, n ¼ 3]) in the
expected proportions.150 | Anal. Methods, 2016, 8, 142–152The electrochemical protocol was explored towards the
ecstasy (synthetic) sample. Fig. 6 shows diﬀerential pulse vol-
tammograms for electrochemical oxidation of ecstasy (a
mixture of MPA andMDMA) using SPEs at concentrations in the
range of 0.00–14.80 mg mL1 and 0.00–16.70 mg mL1 for PMA
and MDMA respectively (in phosphate buﬀer supporting elec-
trolyte) it is possible to see two electrochemical oxidation peaks
for MDMA in +0.86 V and PMA in +1.14 V. Calibration plots for
these two peaks were constructed (see Fig. 6 inset) showing
a linear response over the entire concentration range studied.
Table 2 lists the parameters obtained of the linear response for
PMA/MDMA and the comparison of the electrochemical and
high performance liquid chromatography (HPLC) results which
agree with each other validating our electroanalytical protocol.
Conclusions
For the rst time, the simultaneous detection of MDMA and
PMA using screen-printed graphite electrodes has been re-
ported. This a novel sensing protocol is shown to be both viable
and superior to other analytical techniques (HPLC, Raman) in
terms of speed and cost. Presumptive testing is also shown to be
unable to diﬀerentiate between MDMA and PMA which further
eludes towards the use of the proposed electroanalytical
protocol as an in-the-eld sensor. The electroanalytical protocol
has been validated in a synthetic street sample with HPLC.
Future work is underway to extend this study to seized street
samples with independent validation with HPLC/LS-MS.
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